For instance, both hepatocellular carcinoma (HCC) and gastric cancer (GC) often exhibit abnormal activation of the Wnt/β‐catenin signaling pathway and mutations in the TP53 gene, which promote tumor progression [3, 4]. This evidence concerns the gene TP53 and gastric cancer.